Skip to content

Injectable HIV treatment does as well as daily pills in real-world settings

Dr Alisa Timiryasova at HIV Glasgow 2026. She is standing behind a lectern, with a screen behind her.

Ten-country community testing programme reaches many migrants who have never tested for HIV

Dr Haoyi Wang at HIV Glasgow 2026. He is standing at a lectern, talking into a microphone.

Dolutegravir resistance has not risen in Lesotho cohort

Professor Niklaus Labhardt at HIV Glasgow 2026. He is standing at a lectern.

European guidelines widen access to two-drug HIV treatment

Dr Annalisa Marinosci at HIV Glasgow 2026. She is standing behind a lectern.

A pair of antibodies keeps HIV undetectable by ‘bolting the door and masking the key’

Dr Martin Markowitz at HIV Glasgow 2026. He is standing behind a lectern.

“Normal is the perfect word”: participants describe switching to weekly HIV treatment

Professor Chloe Orkin at HIV Glasgow 2026.

Moving to HIV self-care would be better and cheaper for Africa

A dispensary at a clinic in Mukono, Uganda.

Without US funding, Zimbabwe could see over 75,000 new HIV infections in a year

A family in Zimbabwe - two grandparents and seven children - sit together in a house.

Modelling shows doxyPEP could account for 1.9% of doxycycline use in Europe

A person holds a white pill in one hand and a glass of water in the other.